CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Comparison of Serum HE4 and CA125 Levels in the Detection of Recurrent Ovarian Cancer

Author: 
Isabella Kerubo Ndege, Xiu-gui Sheng, Davis Nsamba, Xiang-wei Lu, Xing Zhen and Xue-lian Du
Subject Area: 
Health Sciences
Abstract: 

Human Epididymis Protein (HE4) is a new promising biomarker in detecting recurrent ovarian cancer. In this study, we investigated the role of serum HE4 in comparison to CA125 in the detection of recurrent disease in patients during follow-up.615 ovarian cancer patients treated at Shandong Provincial Tumor Hospital between 2008 and 2014 were included in the retrospective study. Serum HE4 and CA125 were analyzed during follow-up using the ARCHITECT assay. 131 patients developed recurrent disease. Results showed that a serum HE4 level of 70pmol/L was associated with a sensitivity of 76.3%, a specificity of 89.6%, a negative predictive value of 93.3% and a positive predictive value of 66.6% when assessing for recurrent ovarian cancer whereas CA125 was associated with a sensitivity of 54.9%, a specificity of 79.3%, negative predictive value of 86.6% and a positive predictive value of 41.8%. However, combining CA125 and HE4 at a cut-off of 70pmol/L, the sensitivity, specificity, negative predictive value and positive predictive value increased to 83.9%, 90.9%, 95.4% and 71.4% respectively. These data suggest HE4 is a more sensitive and specific predictor of recurrent disease and should therefore be incorporated with CA125 in detection of recurrent ovarian cancer.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran